Is MTD a good stock to buy?
Mettler-Toledo International Inc. · end-of-day data as of Nov 13, 2026
- MAs4 of 4
- Sector▲ +15.9%
- Earnings in83d
- P/E37.7x
- RSI64
- Support-14.0%
- Off 52w high-3.7%
- Volume0.8x
- Bollingerupper half
- News0.00
- FCF yield+2.5%
- ConsensusHold · 13
- Trendsideways
- 52w range$1,023–$1,807
- ATR+2.6%
- Off ATH-3.7%
- PT$1,532.11 -11.9%
- P/E vs own+21.3%
- P/E vs sector+16.9%
- Insiders-$2.1M
- MACD-3.49
Updates with the 15-min delayed price. Not a forecast or investment advice.
Is Mettler-Toledo a good stock to buy?
Mettler-Toledo is strong on 4 of the 5 questions about the business. The price is high: 37.7 times its earnings, above its 3-year median of 31.7 (Nov 13, 2026). pretickt does not say whether to buy or sell.
- Demand steady
- Advantage hard to copy
- Economics very profitable
- Execution delivers
- Fragility sturdy
- Price expensive
MTD sales growth revenue growth
+1%a year, for the last 3 yearsMettler-Toledo's sales grew 1% a year for 3 years, to $4.03B in fiscal 2025.
MTD analysts' forecast revenue estimates
+6%the sales they expect next fiscal year, on the lastAnalysts expect Mettler-Toledo's sales to grow 6% to $4.27B in fiscal 2026 (8 analysts).
MTD competitors
pretickt analysis+7%its sales in 12 months, on a year before
Mettler-Toledo's sales grew 7% in the 12 months to Sep 30, 2026, faster than Labcorp (+6%) and Illumina (+6%), slower than Quest Diagnostics (+9%) and IQVIA (+9%).
MTD sales by business revenue by segment
56%of its sales from Laboratory products and servicesLaboratory products and services brought Mettler-Toledo 56% of its sales in fiscal 2025; Industrial products and services 39%.
MTD margin after costs profit margin
29%of sales left after running the businessMettler-Toledo's operating margin was 29% in the 12 months to Sep 30, 2026, against 29% in fiscal 2022.
MTD cash generated free cash flow
$871Mcash left after investing, last 12 monthsMettler-Toledo generated $871M of free cash flow in the 12 months to Sep 30, 2026, about as much as its reported profit.
MTD earnings vs estimates
8 of 8quarters above the analysts' estimateMettler-Toledo beat the analysts' profit estimate in each of its last 8 quarters, the latest on Nov 5, 2026.
MTD insider selling
-$20.32Msold, net, by its executives in 12 monthsMettler-Toledo's executives and directors sold a net $20.32M of shares in the 12 months to Nov 13, 2026; none bought.
MTD number of employees
-4%fewer people in a yearMettler-Toledo had 16,600 employees at the end of fiscal 2025, 4% fewer than a year before.
MTD CEO pay
$6.74Mfor fiscal 2025, 73% of it in stock and optionsMettler-Toledo paid its CEO $6.74M for fiscal 2025, 73% of it in stock and options.
MTD financial health Altman Z-score
11.7Altman Z-score, safe above 3Mettler-Toledo's Altman Z-score is 11.7 (Nov 13, 2026), above 3, where the safe zone starts.
MTD quality checks Piotroski score
9 of 9checks passedMettler-Toledo passes all 9 Piotroski checks in the 12 months to Sep 30, 2026.
MTD biggest customers
under 10%of sales from any one customerNo customer made 10% of Mettler-Toledo's sales in fiscal 2025.
MTD in past recessions
pretickt analysis-12%its sales in the worst oneMettler-Toledo's sales fell in 1 of the last 2 US recessions, by as much as 12% in fiscal 2009.
MTD price vs profit P/E ratio
37.7×a year's earningsMettler-Toledo's P/E ratio is 37.7 (Nov 13, 2026), above its 3-year median of 31.7.
MTD price vs competitors
pretickt analysis37.7×a year's earnings, against its competitorsInvestors pay 37.7 times Mettler-Toledo's earnings (Nov 13, 2026), more than for Illumina (35.6), IQVIA (32.2), Labcorp (30.4) or Quest Diagnostics (25.9).
MTD analysts' target price target
-12%to their average targetAnalysts' average price target for Mettler-Toledo is $1,532, 12% below the Nov 13, 2026 close of $1,738.91.
MTD growth priced in fair value
pretickt analysis+16%a year, for ten years, to be worth the priceAt $1,738.91 a share, Mettler-Toledo's free cash flow must grow about 16% a year for ten years to be worth the price (Nov 13, 2026).
What is Mettler-Toledo's P/E ratio?
Mettler-Toledo's P/E ratio is 37.7 (Nov 13, 2026), above its 3-year median of 31.7. Investors pay 37.7 times Mettler-Toledo's earnings (Nov 13, 2026), more than for Illumina (35.6), IQVIA (32.2), Labcorp (30.4) or Quest Diagnostics (25.9).
Who are Mettler-Toledo's biggest competitors?
pretickt compares Mettler-Toledo with Illumina, Labcorp, Quest Diagnostics and IQVIA. Mettler-Toledo's sales grew 7% in the 12 months to Sep 30, 2026, faster than Labcorp (+6%) and Illumina (+6%), slower than Quest Diagnostics (+9%) and IQVIA (+9%).
Is Mettler-Toledo profitable?
Mettler-Toledo's operating margin was 29% in the 12 months to Sep 30, 2026, against 29% in fiscal 2022. Mettler-Toledo generated $871M of free cash flow in the 12 months to Sep 30, 2026, about as much as its reported profit.
Are insiders selling Mettler-Toledo stock?
Mettler-Toledo's executives and directors sold a net $20.32M of shares in the 12 months to Nov 13, 2026; none bought.
How does Mettler-Toledo make money?
Laboratory products and services brought Mettler-Toledo 56% of its sales in fiscal 2025; Industrial products and services 39%.
How many employees does Mettler-Toledo have?
Mettler-Toledo had 16,600 employees at the end of fiscal 2025, 4% fewer than a year before.
Who are Mettler-Toledo's biggest customers?
No customer made 10% of Mettler-Toledo's sales in fiscal 2025.
From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.